NCT02097108
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +16 more
- Locations
-
- PMU Salzburg Salzburg, Austria
- AKH Wien Vienna, Austria
- Ottto Wagner Spital Vienna, Austria
Clinical trial condition
Blood-Borne Infections
Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.
8,279 public trials
443 recruiting studies
Blood-Borne Infections trial results
Completed
Lamivudine(LAM) Good Responder Study
NCT01128686
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Kangwon-do, South Korea
NCT01740115
- Conditions
- Alcohol Drinking, Alcohol Use, Behavior, +23 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
Completed
Fosamprenavir Expanded Access
NCT00240552
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Aarau, Switzerland
- GSK Investigational Site Basel, Switzerland
- GSK Investigational Site Bern, Switzerland
- GSK Investigational Site Bruderholz, Switzerland
NCT01061541
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
NCT01017536
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
- Locations
-
- Aurum Institute Klerksdorp, North West, South Africa
NCT00697554
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT01962155
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +13 more
- Locations
-
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- 302 Military Hospital of China Beijing, Beijing Municipality, China
- Beijing Ditan Hospital Beijing, Beijing Municipality, China
- Peking University First Hospital Beijing, Beijing Municipality, China
Completed
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.
NCT00317174
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
Completed
Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine
NCT00880477
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified